Tag: IFM Therapeutics

IFM and Novartis Sign $840m Collaboration and Option Deal

IFM Therapeutics (IFM), a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, announced that IFM Due, an IFM subsidiary co...

Novartis to Pay Up to $1.6B for Immunology Firm Subsidiary

novartis
Novartis on Monday said it had agreed to pay $310 million upfront, with the possibility for more later, for some research assets of Boston-based inflammation specialist IFM Therapeutics as the Swiss d...